Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Pfizer
Biotech
Moderna's RSV vax nabs FDA breakthrough tag
Moderna continues to chase GSK and Pfizer in the race for the first RSV vaccine, announcing that its candidate has nabbed an FDA breakthrough tag.
Max Bayer
Jan 30, 2023 11:00am
Matt Gline wants you to stop seeing Roivant as a discard company
Jan 25, 2023 10:45am
Concert joins Sun Pharma's symphony in $576M acquisition
Jan 19, 2023 11:30am
Moderna posts come-from-behind RSV data
Jan 17, 2023 4:55pm
BioNTech not giving up on fighting symptomatic COVID
Jan 10, 2023 4:18pm
Roivant CEO: New data could make '23 'single most exciting year'
Jan 10, 2023 9:58am